Endologix (ELGX) Posts Q4 Loss of $0.26/Share; Reaffirms FY19 Revenue Forecast
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Endologix (ELGX) PT Lowered to $1.50 at RBC Capital
February 26, 2019 6:28 AM ESTRBC Capital analyst Glenn Novarro lowered the price target on Endologix (NASDAQ: ELGX) to $1.50 (from $2.00) while maintaining a Sector Perform rating.
The analyst notes 4Q18 revenues and 2019 guidance in line with preannouncement.
... More